BioSpace News Archive

Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico will be a Platinum Sponsor at the Cannapeutas Clinical Perspective Cannabinoid Symposium on Dec. 7 at the National Autonomous University of Mexico in Mexico City.

Paralyzed Veterans of America issued the following statement today in response to the passing of former United States President George H.W. Bush

Guidehouse, a leading provider of management consulting services, announced today the addition of Dr. Harry Greenspun as the firm’s first Chief Medical Officer. Dr. Greenspun brings a wide breadth of both clinical and executive leadership experience to his new role at Guidehouse working with public sector and commercial clients with a focus on health care transformation.

The Parkinson’s Foundation will host its first-ever conference focused on medical marijuana and Parkinson’s disease (PD) in Denver, CO, March 6-7, 2019.

International authority on lymphedema, Stanley G. Rockson, M.D., calls for use of Bioimpedance Spectroscopy as protocol in surveillance and assessment of cancer survivors

BBI (“Bruin Biometrics, LLC”), today announced receipt of a $1.4 million Small Business Innovation Research (SBIR) Phase II program award from The National Institute of Arthritis and Musculoskeletal and Skin division

Bio-Techne has further added to its cell therapy portfolio by expanding the range of Tocris Bioscience-branded cGMP small molecules to include the commonly used stem cell compounds, Y-27632 (ROCK inhibitor) and CHIR 99021.

The vegan movement is gaining momentum as Veganuary expands across the pond from the United Kingdom to the United States.

Kindbody, a company building women’s health clinics starting in New York City and San Francisco, is announcing the hire of Dr. Lynn Westphal from Stanford Medical School as Chief Medical Officer, Reproductive Endocrinology.

Journal of Surgical Research published study shows that reductions in surgical site infection (SSI) lead to substantial cost savings for hospitals